Rafarm S.A
About Rafarm S.A
Categories
-
GR
-
2015On CPHI since
Meet us at
CPHI Frankfurt 2025
Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from Rafarm S.A (39)
-
Product MOXIFLOXACIN HYDROCHLORIDE eye drops solution
Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Conjunctivitis Innovator: Moxivig (Novartis) -
Product CLOPIDOGREL BESILATE f.c. tablets
Strength: 75 mg/tab Therapeutic area: Anti-thrombotic Innovator: Plavix (Sanofi-Aventis) -
Product AMIKACIN solution for injection
Strength: 500 mg/2 ml Presentation: vials, 2 ml Therapeutic area: Anti-infective Innovator: Briklin -
Product ATORVASTATIN f.c. tablets
Strength: 10 mg/tab; 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Diseases Innovator: Lipitor (Pfizer) -
Product BIMATOPROST + TIMOLOL eye drops solution
Strength: (0.3 mg+5 mg)/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Ganfort (Allergan) -
Product BIMATOPROST eye drops solution
Strength: 0.3 mg/ml; 0.1 mg/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Lumigan (Allergan) -
Product BRIMONIDINE + TIMOLOL eye drops solution
Strength: (2 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Combigan (Allergan) -
Product BRIMONIDINE eye drops solution
Strength: 2 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Alphagan (Allergan) -
Product DEXAMETHASONE PRESERVATIVE FREE eye drops solution
Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Treatment of inflammatory conditions of the anterior segment of the eye Innovator: Dexafree (Laboratoires THEA) -
Product DEXAMETHASONE soluble tablets
Strength: 0.5 mg/tab; 2 mg/tab; 4 mg/tab; 8 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Glucocorticoid Therapy Innovator: - (-) -
Product DONEPEZIL f.c. tablets
Strength: 5 mg/tab; 10 mg/tab Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer) -
Product DONEPEZIL oral solution
Strength: 1 mg/ml Presentation: bottles, 150 ml Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance